NAT14 anticorps (N-Term)
Aperçu rapide pour NAT14 anticorps (N-Term) (ABIN2316725)
Antigène
Voir toutes NAT14 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 12-41, N-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- NAT14, NT (NAT14, KLP1, N-acetyltransferase 14, K562 cell-derived leucine-zipper-like protein 1)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of human NAT14.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Autre désignation
- NAT14
-
NCBI Accession
- NP_065111
-
UniProt
- Q8WUY8
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-